This trial is evaluating whether Treatment will improve 1 primary outcome and 5 secondary outcomes in patients with Breast Cancer. Measurement will happen over the course of 5 years.
This trial requires 1670 total participants across 2 different treatment groups
This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 3 and have had some early promising results.
"Breast cancer is not one but many processes: a multi-factorial disease. The most credible theories of breast cancer genesis include (a) age-dependent accumulation of random mutation events (b) sequential acquisition of multiple lesions, and/or (c) the effects of environmental factors on genetic events." - Anonymous Online Contributor
"There is a lot of evidence that women with breast cancer are very reluctant to realize how they are suffering from the disease. Symptoms are very often not identified and not mentioned by women with breast cancer. Symptoms differ greatly between different women." - Anonymous Online Contributor
"In many countries the number of women diagnosed with breast cancer is increasing. Many of these cases are attributable to a range of factors. The most important is increasing numbers of women of reproductive age and the number of breast cancers diagnosed. There is no reason to believe that this is not a public health problem. The major public health issue is the burden of breast cancer, particularly the psychological and psychosocial issues related to it." - Anonymous Online Contributor
"In the United States in 2011 [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) was the most common form of cancer in women. More than half of breast cancer cases in women were initially treated with surgery. In contrast, the rates, of locoregional therapy and chemotherapy are significantly lower in men and women." - Anonymous Online Contributor
"Approximately 10 people get breast cancer in one year in the United States. It is important to inform the community about the risks of breast cancer." - Anonymous Online Contributor
"Despite advances in breast cancer treatment, there is a significant number of women who experience relapse after treatment. New and potentially curative therapies are needed to prevent breast cancer relapse and to reduce the negative impact associated with treatment." - Anonymous Online Contributor
"Breast cancer is diagnosed at its earliest stages and most are non-invasive, which means that mortality is low. There is therefore no reason for alarm or intervention." - Anonymous Online Contributor
"The survival rate for breast cancer is 80%, regardless of initial diagnosis at a younger age (0 to 49 years) and stage of the disease (Stage I and II). Breast cancer, particularly women older than age 50, has undergone an improvement in the prognosis over the past 30 years." - Anonymous Online Contributor
"The familial aggregation of non-BRCA breast cancer families would be consistent with a predominant genetic aetiogenesis model. This model suggests the presence of genetic alterations at the level of the tumor cells (and their immediate progeny) with an additive and/or multiplicative role in the development of breast cancer in hereditary and some sporadic families." - Anonymous Online Contributor
"Although some treatment has been shown to have a potential value in certain settings, most data indicates that when used in combination with other treatments, it is less effective than combined treatment approaches." - Anonymous Online Contributor
"The more important factor in determining spread of [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) was the number of lymph nodes examined. Lymph nodes are the first places the cancer can spread because the larger the number of nodes examined, the less likely a cancer will have been found to be a sentinel node, which is not an option without an axillary radical mastectomy." - Anonymous Online Contributor
"The average age of breast cancer patients diagnosed in the United States is 62 years of age—more than 15 years later than the age at which women are generally expected to develop breast cancer. It may be time to reevaluate breast cancer screening programs." - Anonymous Online Contributor